Overview
- The state begins free Emicizumab prophylaxis via once‑monthly subcutaneous shots, with 108 ambulance support for patients.
- About 2,600 registered patients qualify statewide, with 1,000 high‑risk individuals prioritized for immediate transition.
- A pilot involving roughly 200 patients reported zero bleeds over a year, according to health officials.
- The Cabinet‑approved program secures state funding, with Rs 17 crore earmarked for procurement of the drug from Roche Pharma India.
- Deputy Chief Minister D.K. Shivakumar notes the government’s guarantees strain finances yet portrays the scheme as a welfare necessity.